Sanjivani Paranteral Ltd Share Price

₹220.70 0.70 (0.32%) BSE
as updated on 24-Dec-2025 13:01 | Sector - Healthcare

Day Range

  • Day's Low:220.40
  • Day's High:230.00

  • 52 Week Low170.00
  • 52 Week High396.95

Sanjivani Paranteral Ltd's key Fundamentals

Market Cap ₹270 Cr.
P/E Ratio 36.2
TTM EPS 6.1
P/B Ratio 6.03
ROE 22.95
Debt to Equity 0.15
Face Value 10
BVPS 36.5
3 Year Sales Growth 31.81%

Sanjivani Paranteral Ltd's Share Price Returns

1 Day 0.32%
1 Week 1.00%
1 Month 17.10%
3 Months -8.30%
6 Months 2.30%
1 Years -42.30%
3 Years 467.70%
5 Years 2063.20%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Sanjivani Paranteral Ltd Shareholding Pattern

Promoters

(31.20%)

Institutions

(6.03%)

Non-Institutions

(62.77%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Sanjivani Paranteral Ltd

Sanjivani Parenteral was established in 1997 by A H Khemka, Ashwin Khemka and Somesh Khemka, under the technical direction of Mahendra Kalwankar. It is a research-based, international pharmaceutical company that provides a wide range of high quality products and services at affordable prices. The core product range of the company’s products includes oral solids, small volume parenterals and sterile powder formulations.

The company has grown many folds and aspires to be a respected research-based company. With its diverse product portfolio, it is rapidly expanding its reach to the global marketplace, riding on its success in India and in the world’s emerging and developed markets.

After establishing itself in India, Sanjivani has extended its reach globally by entering the markets of Asia, Europe, Africa and Latin America.  The company has active presence in countries like Russia, Ukraine, Uzbekistan, Turkmenistan, Fiji, Vietnam, Sri Lanka, Nepal, Malaysia, Thailand, Nigeria and Peru, to name a few.  Sanjivani Parenteral has also got its plant approved by the registration authorities of Congo, Sudan and Sri Lanka. It is making its presence felt in the world market now, through leveraging its manufacturing capacity, quality of products and international alliances.

International business contributes about 30% of the company’s revenue and is set to grow to more than 50% in the coming two years. This includes the sales of Sanjivani’s own brands and the revenue from the contract manufacturing services that the company provides to its overseas clients. The company is in the making of a strong base to broaden its horizons. 

Sanjivani has been a regular supplier to the armed forces’ hospitals in India. Furthermore, many government and private hospitals have availed of the products and services offered by Sanjivani across the country.  The company also has its own marketing operations in India and boasts of over 1000 distributors all over India.

Products

  • Therapeutic Products
  • Animal Products
  • Key Products
  • Oral Solids
Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 220.40
  • Day's High: 230.00

  • 52 Week Low170.00
  • 52 Week High396.95

Sanjivani Paranteral Ltd's key Fundamentals

Market Cap ₹270 Cr.
P/E Ratio 36.2
TTM EPS 6.1
P/B Ratio 6.03
ROE 22.95
Debt to Equity 0.15
Face Value 10
BVPS 36.5
3 Year Sales Growth 31.81%

Sanjivani Paranteral Ltd's Share Price Returns

1 Day 0.32%
1 Week 1.00%
1 Month 17.10%
3 Months -8.30%
6 Months 2.30%
1 Years -42.30%
3 Years 467.70%
5 Years 2063.20%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×